1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Product Code | COR L279; CORL279; LuCL4 |
| Species | Human |
| Cat.No | ABC-TC0181 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Lung Small Cell Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
COR-L279 is a human small cell lung cancer (SCLC) cell line that was originally isolated from the lymph node of an untreated 63-year-old male patient. COR-L279 exhibits epithelial-like morphology and suspension culture properties. This cell line has a deletion mutation in TP53.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The COR-L279 human lung small cell carcinoma (SCLC) cell line advances cancer biology through tumor microenvironment investigations and therapeutic target identification. It facilitates drug development by studying chemotherapy efficacy, drug resistance mechanisms, and novel drug discovery while supporting molecular research via genomic profiling for genetic alterations and biomarker discovery for early detection and prognosis. These cells further enable immunotherapy investigations of immune responses and checkpoint inhibitor roles, cell biology studies on cell cycle dysregulation and signaling pathways, and metastasis research examining metastatic cascades and cellular invasion/migration behavior.
